These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12025370)

  • 1. How to study the effects of inflammation on coronary vasomotion and their clinical relevance.
    Gaspardone A; Tomai F
    Ital Heart J; 2002 Apr; 3(4):226-9. PubMed ID: 12025370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The variable role of inflammation in acute coronary syndromes and in restenosis.
    Biasucci LM; Liuzzo G; Buffon A; Maseri A
    Semin Interv Cardiol; 1999 Sep; 4(3):105-10. PubMed ID: 10545616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors.
    Schindler TH; Nitzsche EU; Olschewski M; Magosaki N; Mix M; Prior JO; Facta AD; Solzbach U; Just H; Schelbert HR
    Circulation; 2004 Aug; 110(9):1069-75. PubMed ID: 15313940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plaque temperature in non-culprit de novo atheromatous lesions of patients with acute coronary syndromes.
    Toutouzas K; Drakopoulou M; Mitropoulos J; Tsiamis E; Vaina S; Vavuranakis M; Markou V; Bosinakou E; Stefanadis C
    J Am Coll Cardiol; 2006 Jan; 47(2):301-6. PubMed ID: 16412851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of systemic inflammation with local inflammatory activity in non-culprit lesions: beneficial effect of statins.
    Toutouzas K; Drakopoulou M; Markou V; Karabelas I; Vaina S; Vavuranakis M; Tsiamis E; Tsioufis C; Androulakis A; Stefanadis C
    Int J Cardiol; 2007 Jul; 119(3):368-73. PubMed ID: 17258821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From the single vulnerable plaque, to the multiple complex coronary plaques. From their basis, to the modern therapeutic approach. A clinical reality in the spectrum of the acute coronary syndromes].
    Lupi Herrera E; Chuquiure Valenzuela E; Gaspar J; Férez Santander SM
    Arch Cardiol Mex; 2006; 76 Suppl 1():S6-34. PubMed ID: 16830832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship of C-reactive protein levels with angiographic findings and markers of necrosis in non-ST-segment elevation acute coronary syndrome].
    Sanchís J; Bodí V; Llácer A; Facila L; Martínez-Brotons A; Insa L; Chorro FJ
    Rev Esp Cardiol; 2004 May; 57(5):382-7. PubMed ID: 15151771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased coronary sinus blood temperature: correlation with systemic inflammation.
    Toutouzas K; Drakopoulou M; Markou V; Stougianos P; Tsiamis E; Tousoulis D; Stefanadis C
    Eur J Clin Invest; 2006 Apr; 36(4):218-23. PubMed ID: 16620282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance.
    Golino P; Crea F; Willerson JT
    Ital Heart J; 2002 Apr; 3(4):220-5. PubMed ID: 12025369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient.
    Fichtlscherer S; Breuer S; Zeiher AM
    Circulation; 2004 Oct; 110(14):1926-32. PubMed ID: 15451794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From the single vulnerable plaque, to the multiple complex coronary plaques. From their basis, to the modern therapeutic approach. A clinical reality in the spectrum of the acute coronary syndromes].
    Lupi Herrera E; Chuquiure Valenzuela E; Gaspar Hernández J; Férez Santander SM
    Arch Cardiol Mex; 2006; 76 Suppl 2():S239-40. PubMed ID: 17017109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P; Boyer L; Simard S; Dauwe F; Dupuis R; Verret B; Huynh T; Bertrand F; Dagenais GR; Brophy JM
    J Am Coll Cardiol; 2008 Jun; 51(24):2339-46. PubMed ID: 18549920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammation in acute coronary syndromes: mechanisms and clinical implications].
    Angiolillo DJ; Biasucci LM; Liuzzo G; Crea F
    Rev Esp Cardiol; 2004 May; 57(5):433-46. PubMed ID: 15151777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis: an inflammatory disease.
    Liuzzo G
    Rays; 2001; 26(4):221-30. PubMed ID: 12696277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention.
    Farah R; Shurtz-Swirski R; Bolotin Y; Brezins M
    Minerva Cardioangiol; 2008 Apr; 56(2):189-95. PubMed ID: 18319697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammation, atherosclerosis and acute coronary syndromes].
    Biasucci LM; Santamaria M; Liuzzo G
    Minerva Cardioangiol; 2002 Oct; 50(5):475-86. PubMed ID: 12384630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease.
    Tomai F; Ribichini F; Ghini AS; Ferrero V; Andò G; Vassanelli C; Romeo F; Crea F; Chiariello L
    Eur Heart J; 2005 Oct; 26(20):2099-105. PubMed ID: 15961409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction.
    Ko YG; Jung JH; Park S; Choi E; Joung B; Hwang KC; Ha JW; Choi D; Jang Y; Chung N; Shim WH; Cho SY
    Int J Cardiol; 2006 Sep; 112(1):66-71. PubMed ID: 16309761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1.
    Nomoto K; Oguchi S; Watanabe I; Kushiro T; Kanmatsuse K
    J Cardiol; 2003 Nov; 42(5):201-6. PubMed ID: 14658408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.